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Maria Carmo Pereira Nunes, Wistremundo Dones, Carlos A. Morillo, Juan Justiniano Encina,
Antônio Luiz Ribeiro, on behalf of the Council on Chagas Disease of the Interamerican Society
of Cardiology
Chagas disease caused by the parasite Trypanosoma cruzi is endemic in Latin America.
However, the Centers for Disease Control and Prevention estimates that there are now more
than 300,000 people infected with the Trypanosoma cruzi in the United States with 10% to
15% with active disease. In this state-of-the-art paper, Nunes and colleagues present an
overview of the clinical and epidemiological aspects of the disease. The principles of
treatment of the cardiomyopathy seen in end-stage disease are also discussed.VIEWPOINT VIEWPOINTThe ATLAS ACS–TIMI 51 Trial and the Burden of Missing Data 777
Mori J. Krantz, Sanjay Kaul
Rivaroxaban is a factor Xa inhibitor that was recently reviewed by the Food and Drug
Administration (FDA) as a potential therapy to reduce the risk of recurrent antithrombotic
events in patients with acute coronary syndrome. Approvability of rivaroxaban was considered
largely on the bases of the ATLAS ACS–TIMI 51 trial. The FDA withheld approval
primarily as a result of lack of follow-up data on a signiﬁcant percentage of patients enrolled
in the trial. In this viewpoint paper, Krantz and Kaul discuss the impact of missing data on
this and future cardiovascular outcomes trials with particular emphasis on its effect on
reporting of adverse events and safety outcomes of drugs being studied.(continued on page A-25)
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Florent Le Ven, Mélanie Freeman, John Webb, Marie-Annick Clavel, Miriam Wheeler,
Éric Dumont, Chris Thompson, Robert De Larochellière, Robert Moss, Daniel Doyle,
Henrique B. Ribeiro, Marina Urena, Luis Nombela-Franco, Josep Rodés-Cabau, Philippe Pibarot
Le Ven and colleagues assess the impact of baseline left ventricular (LV) outﬂow, left
ventricular ejection fraction (LVEF), and transvalvular gradient on outcomes following
transcatheter aortic valve replacement (TAVR). Clinical Doppler echocardiographic and
outcome data were prospectively collected in 639 patients undergoing TAVR for
symptomatic severe aortic stenosis. A total of 334 (52.3%) patients had low ﬂow (stroke
volume index <35 ml/m2). These patients had increased 30-day mortality (11.4% vs. 5.9%,
p ¼ 0.01), 2-year all-cause mortality (35.3% vs. 30.9%, p ¼ 0.005), and 2-year cardiovascular
mortality (25.7% vs. 16.8%, p ¼ 0.01) compared to patients with normal ﬂow. Low LVEF
and low mean gradient were not found to be independent predictors of outcome in
multivariate analysis. The authors concluded that low ﬂow but not low LVEF or low gradient
is an independent predictor of early and late mortality following TAVR in high-risk patients
with severe aortic stenosis.CORONARY ARTERY DISEASEGenetics of Coronary Calciﬁcation in Chronic Kidney Disease 789
Jane F. Ferguson, Gregory J. Matthews, Raymond R. Townsend, Dominic S. Raj, Peter A. Kanetsky,
Matthew Budoff, Michael J. Fischer, Sylvia E. Rosas, Radhika Kanthety, Mahboob Rahman,
Stephen R. Master, Atif Qasim, Mingyao Li, Nehal N. Mehta, Haiqing Shen, Braxton D. Mitchell,
Jeffrey R. O’Connell, Alan R. Shuldiner, Weang Kee Ho, Robin Young, Asif Rasheed, John Danesh,
Jiang He, John W. Kusek, Akinlolu O. Ojo, John Flack, Alan S. Go, Crystal A. Gadegbeku,
Jackson T. Wright, Jr, Danish Saleheen, Harold I. Feldman, Daniel J. Rader, Andrea S. Foulkes,
Muredach P. Reilly, and the CRIC Study Principal Investigators
Patients with chronic kidney disease (CKD) have increased coronary artery calciﬁcation
(CAC) and are at higher risk for atherosclerotic coronary heart disease (CHD). Ferguson and
colleagues performed genetic studies of CAC in CKD patients, with the hypothesis that it
may enhance genetic discovery in CHD. Candidate gene study (w2,100 genes, w50,000
single-nucleotide polymorphisms [SNP]) of CAC were performed on the CRIC (Chronic
Renal Insufﬁciency Cohort). SNP with evidence of association in CAC in CRIC were
further examined for association with CAC in the Penn CAC (Pennsylvania Coronary
Artery Calciﬁcation) sample and AFCS (Amish Family Calciﬁcation Study). SNPs with
suggestive replication were further analyzed for association with myocardial infarction (MI)
in the PROMIS (Pakistan Risk of Myocardial Infarction) cohort. Of the 268 SNPs reaching
p < 5  104 for CAC in CRIC, 28 SNPs in 23 loci had nominal support in the same
direction for CAC in Penn CAC or AFCS. In PROMIS, 4 of the 23 suggestive loci
(chr 9 p21, COL 4A1, ATP2BI, and ABCA4) had signiﬁcant association with MI.
In this study, the authors have identiﬁed several loci associated with CAC in CKD that
also relate to MI in a general population sample.
Editorial Comment: Dwight A. Towler, p. 799(continued on page A-26)
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Amir S. Jadidi, Hubert Cochet, Ashok J. Shah, Steven J. Kim, Edward Duncan,
Shinsuke Miyazaki, Maxime Sermesant, Heiko Lehrmann, Matthieu Lederlin, Nick Linton,
Andrei Forclaz, Isabelle Nault, Lena Rivard, Matthew Wright, Xingpeng Liu, Daniel Scherr,
Stephen B. Wilton, Laurent Roten, Patrizio Pascale, Nicolas Derval, Frédéric Sacher, Sebastien Knecht,
Cornelius Keyl, Mélèze Hocini, Michel Montaudon, Francois Laurent, Michel Haïssaguerre, Pierre Jaïs
Atrial fractionated electrograms (CFAEs) are strongly related to anistropic conditions in
patients with atrial ﬁbrillation (AF). However, their relationship to atrial ﬁbrosis is unknown.
Jadidi and colleagues evaluate the relationship between ﬁbrosis by delayed enhancement (DE)
high-resolution atrial magnetic resonance imaging and atrial electrograms in 18 patients with
persistent AF (11 long persistent [lasting 12 months]). Patients with long-persistent versus
persistent AF had statistically signiﬁcant larger left atrial surface area, higher amount of atrial
DE, more CFAE extent, and shorter baseline AF cycle length. Most CFAE (48  14%)
occurred at non-DE left atrial (LA) sites, followed by 41  12% CFAE at patchy DE and 11
 6% at dense DE regions (p ¼ 0.005 and p ¼ 0.008, respectively). A total of 19  6%
CFAE sites occurred at border zones of dense DE. Left atrial electrograms were less
fractionated with longer cycle length and lower voltage at dense DE versus non-DE regions.
The authors concluded that atrial ﬁbrosis as deﬁned by DE magnetic resonance imaging
(MRI) is associated with slower and more organized electrical activity but with lower voltage
than healthy atrial areas. A total of 90% of continuous CFAE sites occurred at non-DE and
patchy DE left atrial sites.
Editorial Comment: Sanjay Dixit, Jeffrey S. Arkles, p. 813HEART RHYTHM DISORDERSAir Pollution and Atrial Fibrillation 816
Mark S. Link, Heike Luttmann-Gibson, Joel Schwartz, Murray A. Mittleman, Benjamin Wessler,
Diane R. Gold, Douglas W. Dockery, Francine Laden
Link and colleagues evaluate the association of air pollution with the onset of atrial ﬁbrillation
(AF). Patients with prior dual chamber implantable cardioverter-deﬁbrillators were followed.
The association of AF onset with air quality including ﬁne particulate matter (PM 2.5) was
examined. The odds of AF increased by 26% for each 6.0 mg/m3 increased in PM 2.5 in the
2 h prior to the event (p ¼ 0.004). The odds of AF were highest at the upper quartile of mean
PM 2.5. This study reveals that particulate matter is associated with increased odds of AF
onset within hours following exposure in patients with known coronary artery disease.(continued on page A-27)
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Michael J. Lipinski, Courtney M. McVey, Jeffrey S. Berger, Christopher M. Kramer, Michael Salerno
Lipinski and colleagues performed a systematic review and meta-analysis to understand
the role of stress cardiac magnetic resonance imaging (CMR) in assessing cardiovascular
prognosis in patients with known or suspected coronary artery disease. Review of the
literature revealed 19 studies with a total of 11,636 patients and mean follow-up of
32 months. Patients had a mean age 63  12 years, 26% with prior myocardial infarction
(MI), left ventricular ejection fraction 61  12%, late gadolinium enhancement (LGE) in
29%, and ischemia in 32%. Patients with ischemia had a higher incidence of MI (odds ratio:
7.7; p < 0.0001) as compared with those with a negative study. The presence of LGE was
signiﬁcantly associated with worse prognosis. The authors conclude that stress CMR has
excellent prognostic characteristics with a negative stress CMR associated with very low risk
of cardiovascular death or MI.
Editorial Comment: Raymond H. Chan, Warren J. Manning, p. 839CARDIOMYOPATHYDynamic Obstruction in Hypertrophic Cardiomyopathy 842
Stéphane Laﬁtte, Patricia Reant, Cecile Touche, Xavier Pillois, Marina Dijos, Florence Arsac,
Jerome Peyrou, Michel Montaudon, Philippe Ritter, Raymond Roudaut, Anthony DeMaria
A subset of patients with hypertrophic cardiomyopathy (HCM), have excellent exercise
tolerance despite a signiﬁcant intraventricular gradient (>50 mm Hg). Laﬁtte and colleagues
analyze left ventricular (LV) obstruction in 107 HCM patients during exercise echocardiography.
Of the 38 patients with a resting intraventricular gradient, 9 exhibited a decrease in gradient
of at least 30 mm Hg (99  35 mm Hg to 30  14 mm Hg, p < 0.001) during exercise
(paradoxical response to exercise [PRE]). PRE patients had signiﬁcantly lower New York
Heart Association functional class and higher left ventricular volumes and atrial pressure both
at rest and during exercise as compared with HCM patients with increase or no change in
gradient. The authors have identiﬁed a subgroup of HCM patients (PRE) with decrease in
intraventricular gradient during exercise and which may account for a better functional class
and a trend to less clinical events.(continued on page A-28)
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Pascal Stammet, Daniel R. Wagner, Georges Gilson, Yvan Devaux
The authors evaluate the use of biomarkers, neuron-speciﬁc emolase (NSE) and neuron-
enriched S100 beta (S100b), as well as a bispectral index (electroencephalographic
monitoring [BIS]) to predict outcome after cardiac arrest. A total of 75 patients with cardiac
arrest treated with therapeutic hypothermia were enrolled. Primary endpoint was neurological
outcome deﬁned by cerebral performance category (CPC) at 6 months (scores 1 to 2 ¼ good
outcome and 3 to 5 ¼ poor outcome); 46 (61%) patients survived at 6 months and 41 (55%)
patients had CPC 1 to 2. Levels of NSE and S100b were higher in patients with poor
outcomes compared to patients with good outcomes (4-fold and 10-fold, respectively;
p < 0.001). BIS was lower in patients with good outcome (10-fold, p < 0.001). Patients with
S100b level above 0.03 mg/l and BIS below 5.5 had a 3.6-fold higher risk of poor
neurological outcome (p < 0.0001). S100b and BIS predicted 6 months mortality. The
authors conclude that combined determination of serum levels of S100b and BIS monitoring
accurately predicts outcome after cardiac arrest.
